Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 16.72% | 28.48% | 12.70% | 7.38% | |
| Total Other Revenue | -4.57% | 25.90% | 7.15% | -13.09% | |
| Total Revenue | 15.25% | 28.28% | 12.30% | 5.71% | |
| Cost of Revenue | -2.88% | 21.44% | 6.42% | -5.67% | |
| Gross Profit | 22.25% | 31.42% | 14.75% | 10.71% | |
| SG&A Expenses | 7.99% | 22.79% | 10.60% | 2.04% | |
| Depreciation & Amortization | 46.88% | 43.55% | -2.75% | -20.09% | |
| Other Operating Expenses | 9.35% | 99.96% | 50.84% | 44.61% | |
| Total Operating Expenses | 8.28% | 28.05% | 15.57% | 2.34% | |
| Operating Income | 51.99% | 29.70% | -2.26% | 20.95% | |
| Income Before Tax | -43.23% | -295.79% | 15.64% | 95.12% | |
| Income Tax Expenses | 97.23% | -452.92% | -11.52% | 348.34% | |
| Earnings from Continuing Operations | -69.35% | -264.26% | 22.65% | 68.49% | |
| Earnings from Discontinued Operations | -100.00% | 107.65% | 6,439.06% | 7.43% | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -754.96% | 27.60% | -8.47% | -56.59% | |
| Net Income | -91.24% | -356.99% | 276.56% | 60.17% | |
| EBIT | 51.99% | 29.70% | -2.26% | 20.95% | |
| EBITDA | 51.93% | 30.47% | 1.14% | -2.19% | |
| EPS Basic | -91.09% | -367.82% | 286.74% | 62.11% | |
| Normalized Basic EPS | 37.97% | -- | -- | -- | |
| EPS Diluted | -91.14% | -369.88% | 289.34% | 62.11% | |
| Normalized Diluted EPS | 37.97% | -- | -- | -- | |
| Average Basic Shares Outstanding | -1.68% | -3.09% | -2.59% | -1.19% | |
| Average Diluted Shares Outstanding | -1.68% | -3.46% | -2.93% | -1.19% | |
| Dividend Per Share | -- | 14.78% | -- | -- | |
| Payout Ratio | 10.85% | -8.04% | -0.42% | -- | |